Search Results - "Hinojosa Segura, CI"

The Stroop test validation in the detection of minimal hepatic encephalopathy in Mexican patients with cirrhosis, preliminary results by Domínguez Cardoso, PF, Pérez Hernández, JL, Higuera de la Tijera, F, Santana Vargas, AD, Montemira Orozco, D, Hinojosa Segura, CI

“…Minimal hepatic encephalopathy (MHE) is an important cause of morbi-mortality in patients with cirrhosis; its timely identification has an impact on prognosis;…”
Get full text

Changes in early visual perception in patients with minimal hepatic encephalopathy by Montemira-Orozco, D, Hinojosa-Segura, CI, Burak-Leipuner, A, Zavala-Ramírez, J, Cruz-Reyes, IG, Escobedo-Silva, M, Higuera-de la Tijera, F, Pérez-Hernández, JL, Santana-Vargas, D

“…Minimal Hepatic Encephalopathy (MHE) is characterized by very subtle cognitive changes that are diagnosed with the Psychometric hepatic encephalopathy score…”
Get full text

Short-term response of p300 evoked potential in patients with minimal hepatic encephalopathy treated with l-ornithine, l-aspartate by Hinojosa-Segura, CI, Montemira-Orozco, D, Burak-Leipuner, A, Zavala-Ramírez, J, Cruz-Reyes, IG, Escobedo-Silva, M, Higuera-de la Tijera, F, Pérez-Hernández, JL, Santana-Vargas, D

“…The clinical alterations of Minimal Hepatic Encephalopathy (MHE) include subtle changes in cognitive processes detectable only with tests such as the…”
Get full text

Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study by Moreno-Cobos, AB, Higuera-de la Tijera, F, Hinojosa-Segura, CI, Montemira-Orozco, D, Reyes-Méndez, J, Cruz-Reyes, IG, Zavala-Ramírez, J, Santana-Vargas, D, Servín-Caamaño, A, Abdo-Francis, JM, Hernandez, JL Pérez

“…MHE is related to a higher risk of accidents and deterioration in the quality of life; it can be detected with PHES and CFP. There is currently insufficient…”
Get full text

Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients by Burak-Leipuner, A, García-Gorrosquieta, F, Uribe-Rivera, N, Servín-Caamaño, A, Romero-Bermúdez, JA, Ceceña-Martínez, LE, Alagón-Fernández del Campo, P, Vargas-Duran, FY, Soto-Martinez, AK, Hinojosa-Segura, CI, Montemira-Orozco, D, Perez-Hernández, JL, Alexanderson-Rosas, G, Higuera-de la Tijera, F

“…Younossi ZM et al.have recently reported a higher prevalence of fatty liver disease associated with metabolic dysfunction (MAFLD) in diabetics (55.5%) versus…”
Get full text

Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients with liver cirrhosis by Gutiérrez, O Morales, Leipuner, A Burak, de Campo, P Alagón Fernandez, Duran, F Vargas, Segura, CI Hinojosa, Orozco, D Montemira, Vargas, AD Santana, Higuera de la Tijera, MF, Pérez Hernández, JL

“…Sarcopenia, defined as loss of muscle mass and strength, and minimal hepatic encephalopathy (MHE), alter the quality of life and prognosis of patients with…”
Get full text